Walleye Capital
AGL icon

Walleye Capital’s Agilon Health AGL Stock Holding History

Walleye Capital’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$103 – 4509
2025
Q3 		$103 Sell
4
-176
-98% -$6.65K ﹤0.01% 4397
2025
Q2 		$10.3K Buy
+180
New +$14.4K ﹤0.01% 4306
2025
Q1 		– Sell
-5,056
Closed -$240K – 4178
2024
Q4 		$240K Sell
5,056
-3,264
-39% -$197K ﹤0.01% 3615
2024
Q3 		$817K Buy
8,320
+3,764
+83% +$486K ﹤0.01% 2847
2024
Q2 		$745K Buy
4,556
+1,292
+40% +$184K ﹤0.01% 3127
2024
Q1 		$498K Buy
3,264
+1,912
+141% +$318K ﹤0.01% 3201
2023
Q4 		$424K Sell
1,352
-472
-26% -$171K ﹤0.01% 3080
2023
Q3 		$810K Buy
+1,824
New +$824K ﹤0.01% 2432

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Walleye Capital's AGL Position: Q4 2025 in Review

Walleye Capital sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 563 shares — an estimated $14.5K sold.

Walleye Capital first reported a position in AGL in Q4 2021 and held it in 7 quarters. The position peaked at $1.23M in Q2 2024. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Walleye Capital reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 563 Agilon Health shares in Q4 2025, an estimated $14.5K.
  • Walleye Capital first reported a position in Agilon Health in Q4 2021 and held it in 7 quarters.
  • Walleye Capital's Agilon Health position peaked at $1.23M in Q2 2024.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.